VASOPRESSIN

VASOPRESSIN was reported 4443 times

VASOPRESSIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 APPENDICOLITH 269 0.6951
1 ANTACID THERAPY 67 0.5154
2 SLEEP DISORDER THERAPY 91 0.4596
3 OESOPHAGEAL ADENOCARCINOMA RECURRENT 3 0.3333
4 VITAMIN B1 INCREASED 15 0.3191
5 ANALGESIC THERAPY 102 0.3178
6 DRUG THERAPY 97 0.2861
7 ANTICOAGULANT THERAPY 66 0.2324
8 CARDIAC OUTPUT INCREASED 30 0.1754
9 BLOOD LACTIC ACID DECREASED 30 0.1744
10 VITAMIN B1 DECREASED 34 0.1355
11 BACTEROIDES INFECTION 35 0.1341
12 CONGENITAL HIATUS HERNIA 28 0.1228
13 MALIGNANT MELANOMA STAGE 0 24 0.1148
14 BURKHOLDERIA TEST POSITIVE 14 0.1129
15 ELECTROCARDIOGRAM U WAVE PRESENT 7 0.1129
16 MEAN ARTERIAL PRESSURE INCREASED 6 0.0857
17 HYPERDYNAMIC LEFT VENTRICLE 18 0.0732
18 BLOOD PHOSPHORUS INCREASED 171 0.0626
19 HYPERPHOSPHATAEMIA 132 0.0613
20 SEPTIC CARDIOMYOPATHY 3 0.0600
21 VASOPLEGIA SYNDROME 85 0.0518
22 JUNCTIONAL ECTOPIC TACHYCARDIA 3 0.0517
23 CARDIAC ARREST NEONATAL 7 0.0507
24 WERNICKE-KORSAKOFF SYNDROME 3 0.0476
25 EXPOSURE VIA CONTAMINATED DEVICE 2 0.0455
26 EXTRACORPOREAL MEMBRANE OXYGENATION 2 0.0444
27 DRY GANGRENE 28 0.0441
28 MEAN ARTERIAL PRESSURE DECREASED 11 0.0435
29 MYOCARDIAL CALCIFICATION 5 0.0427
30 HARLEQUIN SYNDROME 3 0.0411
31 HAND AMPUTATION 3 0.0357
32 BLOOD LACTIC ACID ABNORMAL 4 0.0357
33 DRUG HALF-LIFE INCREASED 4 0.0351
34 CLINICAL TRIAL PARTICIPANT 2 0.0351
35 DISTRIBUTIVE SHOCK 77 0.0340
36 BACTERIAL PERICARDITIS 2 0.0339
37 NEONATAL CARDIAC FAILURE 3 0.0333
38 PULMONARY HAEMORRHAGE NEONATAL 3 0.0326
39 HEPATIC ISCHAEMIA 10 0.0322
40 TOTAL LUNG CAPACITY DECREASED 51 0.0319
41 AUTOIMMUNE HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0317
42 CARCINOID CRISIS 7 0.0310
43 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 28 0.0302
44 CYTOTOXIC OEDEMA 8 0.0302
45 GASTROINTESTINAL MUCORMYCOSIS 5 0.0299
46 CARDIOGENIC SHOCK 428 0.0298
47 CARDIAC INDEX DECREASED 3 0.0291
48 APPENDICITIS 270 0.0289
49 ELECTROCARDIOGRAM P WAVE ABNORMAL 7 0.0286
50 ANION GAP 18 0.0284
51 ATELECTASIS NEONATAL 3 0.0278
52 DIABETES INSIPIDUS 66 0.0274
53 DRUG-DEVICE INTERACTION 3 0.0270
54 CSF PRESSURE INCREASED 7 0.0263
55 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 9 0.0259
56 MYOCARDIAL NECROSIS 6 0.0258
57 ENTEROBACTER PNEUMONIA 4 0.0256
58 BLOOD URIC ACID INCREASED 141 0.0244
59 IRON DEFICIENCY 108 0.0240
60 VENTRICULAR FIBRILLATION 242 0.0218
61 AORTIC STENOSIS 74 0.0212
62 ELECTROCARDIOGRAM T WAVE AMPLITUDE DECREASED 7 0.0206
63 NECROSIS ISCHAEMIC 9 0.0195
64 LUNG OPACITY 50 0.0190
65 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 96 0.0189
66 HYPERLACTACIDAEMIA 48 0.0179
67 HYPOPHOSPHATAEMIA 132 0.0178
68 MYASTHENIA GRAVIS 144 0.0178
69 PNEUMONITIS ASPIRATION 6 0.0175
70 NECROTISING SOFT TISSUE INFECTION 4 0.0173
71 PULMONARY ARTERIAL WEDGE PRESSURE INCREASED 3 0.0172
72 BLINDNESS CORTICAL 8 0.0163
73 PROPOFOL INFUSION SYNDROME 11 0.0156
74 MULTIPLE ORGAN DYSFUNCTION SYNDROME 424 0.0150
75 NEWBORN PERSISTENT PULMONARY HYPERTENSION 4 0.0142
76 CRUSH SYNDROME 2 0.0142
77 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 15 0.0141
78 WRONG PRODUCT STORED 4 0.0141
79 NECROTISING OESOPHAGITIS 7 0.0140
80 PERIPHERAL ISCHAEMIA 57 0.0139
81 LEFT VENTRICULAR END-DIASTOLIC PRESSURE INCREASED 3 0.0139
82 ISCHAEMIC HEPATITIS 19 0.0139
83 PERIORBITAL HAEMORRHAGE 3 0.0138
84 VASOCONSTRICTION 12 0.0137
85 LEFT VENTRICULAR DILATATION 7 0.0137
86 BANDAEMIA 2 0.0136
87 NEONATAL HYPOTENSION 5 0.0136
88 FOETAL EXPOSURE DURING DELIVERY 9 0.0133
89 ENTEROBACTER BACTERAEMIA 4 0.0132
90 MATERNAL EXPOSURE DURING DELIVERY 13 0.0131
91 RETINAL ISCHAEMIA 8 0.0131
92 BLOOD INSULIN DECREASED 2 0.0129
93 NEONATAL ASPHYXIA 9 0.0127
94 ALLOGENIC STEM CELL TRANSPLANTATION 2 0.0127
95 DEVICE PROGRAMMING ERROR 4 0.0126
96 CARDIAC FAILURE HIGH OUTPUT 3 0.0124
97 PULSELESS ELECTRICAL ACTIVITY 52 0.0124
98 NON-CARDIOGENIC PULMONARY OEDEMA 13 0.0123
99 PURPURA FULMINANS 3 0.0118
100 ACUTE RIGHT VENTRICULAR FAILURE 2 0.0118
101 LABORATORY TEST INTERFERENCE 9 0.0115
102 MYOCARDIAL INJURY 12 0.0107
103 AEROMONAS INFECTION 2 0.0106
104 HYPOPERFUSION 11 0.0105
105 HAEMODYNAMIC INSTABILITY 79 0.0104
106 EXTREMITY NECROSIS 18 0.0103
107 LIMB AMPUTATION 4 0.0101
108 ASCITES 293 0.0100
109 TROPONIN INCREASED 73 0.0096
110 COMPARTMENT SYNDROME 25 0.0096
111 SYSTOLIC DYSFUNCTION 10 0.0095
112 ABDOMINAL COMPARTMENT SYNDROME 6 0.0094
113 ACUTE LUNG INJURY 11 0.0093
114 BRASH SYNDROME 13 0.0093
115 HYPERMAGNESAEMIA 6 0.0092
116 ANION GAP INCREASED 12 0.0090
117 ACUTE LEFT VENTRICULAR FAILURE 6 0.0089
118 INTESTINAL ISCHAEMIA 49 0.0089
119 SHOCK 203 0.0088
120 COLOUR BLINDNESS 8 0.0087
121 PERFORATION 7 0.0087
122 PANCREATITIS HAEMORRHAGIC 4 0.0086
123 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 44 0.0086
124 PLEURITIC PAIN 23 0.0083
125 HERBAL INTERACTION 3 0.0083
126 BLASTOMYCOSIS 4 0.0082
127 METHAEMOGLOBINAEMIA 19 0.0082
128 RESPIRATORY GAS EXCHANGE DISORDER 3 0.0081
129 BACTERIAL INFECTION 150 0.0080
130 BLOOD CALCIUM INCREASED 67 0.0076
131 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 130 0.0076
132 EMBOLISM ARTERIAL 9 0.0075
133 RIGHT VENTRICULAR DYSFUNCTION 8 0.0073
134 COMA SCALE ABNORMAL 21 0.0072
135 BRADYCARDIA FOETAL 6 0.0072
136 CANDIDA TEST POSITIVE 3 0.0072
137 ACUTE RESPIRATORY DISTRESS SYNDROME 127 0.0072
138 CONTINUOUS HAEMODIAFILTRATION 7 0.0072
139 PULSE ABSENT 34 0.0071
140 ISCHAEMIA 32 0.0070
141 OPTIC NERVE INJURY 8 0.0069
142 HYPERLIPIDAEMIA 82 0.0069
143 OPTIC ATROPHY 11 0.0067
144 CONGESTIVE HEPATOPATHY 3 0.0067
145 LOCKED-IN SYNDROME 3 0.0065
146 HEPARIN-INDUCED THROMBOCYTOPENIA 32 0.0065
147 FUNGAEMIA 10 0.0063
148 RESPIRATORY SYMPTOM 18 0.0063
149 BRONCHOPULMONARY DYSPLASIA 5 0.0062
150 PNEUMONIA NECROTISING 4 0.0062
151 INTRAVENTRICULAR HAEMORRHAGE NEONATAL 3 0.0062
152 BLOOD OSMOLARITY INCREASED 2 0.0061
153 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 12 0.0061
154 METABOLIC ACIDOSIS 193 0.0060
155 HYPERNATRAEMIA 30 0.0060
156 ACIDOSIS 46 0.0060
157 GANGRENE 36 0.0060
158 CEREBELLAR INFARCTION 10 0.0059
159 BEZOAR 8 0.0058
160 PUPIL FIXED 10 0.0058
161 HYPOTONIA NEONATAL 9 0.0058
162 FOETAL HYPOKINESIA 4 0.0057
163 ENTEROCOCCAL BACTERAEMIA 6 0.0057
164 LACTIC ACIDOSIS 181 0.0056
165 MULTI-ORGAN FAILURE 96 0.0055
166 CARCINOID SYNDROME 2 0.0055
167 HYPERVOLAEMIA 27 0.0055
168 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 12 0.0055
169 RETINOPATHY OF PREMATURITY 3 0.0054
170 NEURALGIA 130 0.0053
171 RESPIRATORY ACIDOSIS 21 0.0053
172 VENTRICULAR HYPOKINESIA 17 0.0053
173 KLEBSIELLA BACTERAEMIA 5 0.0053
174 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 14 0.0053
175 ALKALOSIS 2 0.0052
176 BENIGN PROSTATIC HYPERPLASIA 27 0.0052
177 RIGHT VENTRICULAR DILATATION 3 0.0052
178 HYPONATRAEMIA 292 0.0052
179 OLIGURIA 32 0.0051
180 ESCHERICHIA TEST POSITIVE 6 0.0050
181 VENTRICULAR ARRHYTHMIA 18 0.0049
182 INFANTILE APNOEA 4 0.0049
183 END STAGE RENAL DISEASE 89 0.0049
184 PHARYNGEAL HAEMORRHAGE 6 0.0049
185 BRAIN DEATH 15 0.0048
186 STRESS CARDIOMYOPATHY 28 0.0048
187 BRAIN HERNIATION 14 0.0047
188 GOUT 84 0.0047
189 NODAL ARRHYTHMIA 4 0.0046
190 BLOOD TEST ABNORMAL 65 0.0046
191 TONIC CLONIC MOVEMENTS 6 0.0046
192 SPLENIC INFARCTION 8 0.0046
193 INTESTINAL PSEUDO-OBSTRUCTION 4 0.0046
194 ENTEROCUTANEOUS FISTULA 4 0.0045
195 ANURIA 39 0.0045
196 ULCER 72 0.0045
197 MITRAL VALVE STENOSIS 3 0.0045
198 CAECITIS 2 0.0044
199 PRODUCT OUTER PACKAGING ISSUE 4 0.0044
200 DISSEMINATED INTRAVASCULAR COAGULATION 62 0.0044
201 ANTICHOLINERGIC SYNDROME 7 0.0044
202 CYTOKINE STORM 3 0.0044
203 BLOOD LACTIC ACID INCREASED 23 0.0044
204 VASOSPASM 4 0.0044
205 SEPTIC SHOCK 189 0.0043
206 NEPHROGENIC DIABETES INSIPIDUS 5 0.0043
207 NEUROLOGICAL DECOMPENSATION 10 0.0043
208 ANGLE CLOSURE GLAUCOMA 11 0.0043
209 LIVEDO RETICULARIS 9 0.0043
210 BREATH SOUNDS ABNORMAL 21 0.0043
211 PNEUMATOSIS INTESTINALIS 12 0.0042
212 ELECTROCARDIOGRAM ABNORMAL 33 0.0042
213 PRODUCT CONTAMINATION MICROBIAL 5 0.0042
214 HAEMATOMA MUSCLE 5 0.0042
215 BLOOD BICARBONATE INCREASED 2 0.0042
216 ALANINE AMINOTRANSFERASE DECREASED 3 0.0041
217 SYMPTOM MASKED 3 0.0041
218 PRODUCT PACKAGING CONFUSION 10 0.0041
219 DRUG-DISEASE INTERACTION 3 0.0041
220 HAEMOPHILUS INFECTION 4 0.0041
221 OSMOTIC DEMYELINATION SYNDROME 3 0.0041
222 CEREBRAL VASOCONSTRICTION 3 0.0041
223 HYPERTHERMIA MALIGNANT 6 0.0040
224 FEAR OF DEATH 9 0.0040
225 HEART SOUNDS ABNORMAL 3 0.0040
226 BRADYCARDIA NEONATAL 5 0.0040
227 PNEUMOMEDIASTINUM 7 0.0039
228 ASPARTATE AMINOTRANSFERASE DECREASED 2 0.0038
229 SEPSIS 415 0.0037
230 RIGHT VENTRICULAR FAILURE 26 0.0037
231 BRADYPNOEA 10 0.0037
232 INTENTIONAL OVERDOSE 237 0.0037
233 PULMONARY ARTERIAL PRESSURE INCREASED 6 0.0037
234 RESPIRATORY DEPRESSION 45 0.0037
235 METABOLIC ENCEPHALOPATHY 11 0.0037
236 BLOOD PH INCREASED 2 0.0036
237 RENAL TUBULAR NECROSIS 35 0.0036
238 MULTI-ORGAN DISORDER 7 0.0036
239 COLITIS ISCHAEMIC 24 0.0036
240 HYPOXIA 125 0.0035
241 PROCEDURAL HYPOTENSION 3 0.0035
242 VITAL FUNCTIONS ABNORMAL 3 0.0035
243 CARDIORENAL SYNDROME 2 0.0035
244 ARTERIOSPASM CORONARY 14 0.0035
245 VENTRICULAR DYSFUNCTION 9 0.0035
246 RENAL INFARCT 5 0.0035
247 HAEMOTHORAX 10 0.0034
248 FEAR 91 0.0034
249 CANDIDA SEPSIS 3 0.0033
250 VENTRICULAR TACHYCARDIA 55 0.0033
251 RIGHT VENTRICULAR HYPERTROPHY 3 0.0033
252 PNEUMONIA KLEBSIELLA 6 0.0033
253 BLOOD CHOLESTEROL INCREASED 152 0.0033
254 HYPOTHERMIA 33 0.0033
255 CARDIAC ARREST 269 0.0033
256 CIRCULATORY COLLAPSE 55 0.0032
257 INTRAVENTRICULAR HAEMORRHAGE 8 0.0032
258 ASPIRATION 35 0.0032
259 HEPATIC NECROSIS 12 0.0032
260 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
261 ELECTROCARDIOGRAM T WAVE INVERSION 7 0.0032
262 TROPONIN T INCREASED 4 0.0032
263 SEROTONIN SYNDROME 60 0.0031
264 NECROTISING FASCIITIS 11 0.0031
265 ANOXIC ENCEPHALOPATHY 2 0.0031
266 CARDIAC VENTRICULAR THROMBOSIS 4 0.0031
267 RALES 18 0.0031
268 SINUS ARRHYTHMIA 4 0.0031
269 RENAL INJURY 91 0.0031
270 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 10 0.0030
271 ACUTE RESPIRATORY FAILURE 58 0.0030
272 COAGULOPATHY 50 0.0030
273 HYPERCAPNIA 9 0.0030
274 STATUS EPILEPTICUS 33 0.0029
275 CAPILLARY LEAK SYNDROME 6 0.0029
276 NECROSIS 16 0.0029
277 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 4 0.0028
278 TUMOUR NECROSIS 3 0.0028
279 PRODUCT NAME CONFUSION 3 0.0027
280 ABDOMINAL DISTENSION 287 0.0027
281 ACINETOBACTER INFECTION 3 0.0027
282 PNEUMONIA STREPTOCOCCAL 3 0.0027
283 NODAL RHYTHM 4 0.0027
284 ANHEDONIA 71 0.0027
285 PUPILLARY REFLEX IMPAIRED 5 0.0027
286 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 140 0.0027
287 ARTERIAL INJURY 2 0.0027
288 CREATININE RENAL CLEARANCE INCREASED 2 0.0027
289 BLOOD CULTURE POSITIVE 8 0.0027
290 BRAIN STEM SYNDROME 2 0.0027
291 KLEBSIELLA SEPSIS 3 0.0027
292 DIFFUSE ALVEOLAR DAMAGE 3 0.0026
293 ASPIRATION PLEURAL CAVITY 2 0.0026
294 RESPIRATORY FAILURE 189 0.0026
295 ARTERIAL THROMBOSIS 5 0.0026
296 HYPOTENSION 517 0.0026
297 GENERAL PHYSICAL HEALTH DETERIORATION 297 0.0026
298 BRADYCARDIA 135 0.0025
299 CARDIOMYOPATHY 37 0.0025
300 BRONCHIAL HYPERREACTIVITY 3 0.0025
301 ANTIPHOSPHOLIPID SYNDROME 4 0.0025
302 STRONGYLOIDIASIS 4 0.0025
303 LIVER FUNCTION TEST INCREASED 53 0.0025
304 RETROPERITONEAL HAEMORRHAGE 6 0.0024
305 LEUKOCYTOSIS 44 0.0024
306 SUPRAVENTRICULAR TACHYCARDIA 23 0.0024
307 SYSTEMIC CANDIDA 6 0.0024
308 PRODUCT USED FOR UNKNOWN INDICATION 3 0.0024
309 BRONCHIECTASIS 16 0.0024
310 BUNDLE BRANCH BLOCK LEFT 10 0.0024
311 APTYALISM 2 0.0023
312 APGAR SCORE LOW 3 0.0023
313 RECALLED PRODUCT 4 0.0023
314 CARDIOPULMONARY FAILURE 9 0.0023
315 TORSADE DE POINTES 18 0.0023
316 PSEUDOMONAL SEPSIS 4 0.0023
317 CYTOKINE RELEASE SYNDROME 45 0.0022
318 ACUTE KIDNEY INJURY 342 0.0022
319 INTRA-ABDOMINAL FLUID COLLECTION 4 0.0022
320 ANAEMIA OF CHRONIC DISEASE 2 0.0022
321 SPUTUM DISCOLOURED 21 0.0022
322 STENOTROPHOMONAS INFECTION 3 0.0022
323 MICTURITION URGENCY 25 0.0022
324 CONDUCTION DISORDER 4 0.0022
325 HYPERCHOLESTEROLAEMIA 21 0.0022
326 LOBAR PNEUMONIA 4 0.0022
327 CARDIAC DYSFUNCTION 8 0.0021
328 ENDOTRACHEAL INTUBATION 6 0.0021
329 BRAIN STEM HAEMORRHAGE 2 0.0021
330 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 116 0.0021
331 MECHANICAL VENTILATION 4 0.0021
332 CEREBELLAR HAEMORRHAGE 3 0.0021
333 COR PULMONALE 2 0.0021
334 DRY MOUTH 170 0.0021
335 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
336 ILEUS 26 0.0021
337 HYPOVOLAEMIC SHOCK 10 0.0021
338 URINE OUTPUT DECREASED 18 0.0021
339 CARDIAC FIBRILLATION 3 0.0020
340 TOXICITY TO VARIOUS AGENTS 343 0.0020
341 DEVICE INFUSION ISSUE 5 0.0020
342 CREPITATIONS 6 0.0020
343 GASTRITIS HAEMORRHAGIC 3 0.0020
344 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
345 ASPARTATE AMINOTRANSFERASE INCREASED 106 0.0020
346 DIABETES MELLITUS 152 0.0020
347 FULL BLOOD COUNT ABNORMAL 21 0.0020
348 VASODILATATION 5 0.0020
349 NEUTROPENIC SEPSIS 14 0.0020
350 INTRACARDIAC THROMBUS 6 0.0020
351 PREMATURE DELIVERY 31 0.0019
352 RHABDOMYOLYSIS 81 0.0019
353 ATRIOVENTRICULAR BLOCK COMPLETE 13 0.0019
354 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
355 HYPERTROPHIC CARDIOMYOPATHY 3 0.0019
356 AKINESIA 4 0.0019
357 SINUS ARREST 3 0.0019
358 BRAIN OEDEMA 24 0.0019
359 PRODUCT LABEL CONFUSION 11 0.0019
360 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 4 0.0019
361 METABOLIC ALKALOSIS 3 0.0019
362 ENTEROCOCCAL INFECTION 9 0.0019
363 ANTICONVULSANT DRUG LEVEL INCREASED 3 0.0019
364 TRANSAMINASES INCREASED 41 0.0018
365 STAPHYLOCOCCAL BACTERAEMIA 8 0.0018
366 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0018
367 EMBOLISM 15 0.0018
368 THROMBOSIS 145 0.0018
369 TROPONIN I INCREASED 3 0.0018
370 BRAIN INJURY 18 0.0018
371 GASTROINTESTINAL HYPOMOTILITY 4 0.0018
372 PATENT DUCTUS ARTERIOSUS 7 0.0018
373 BLOOD PH DECREASED 3 0.0018
374 ARTERIAL HAEMORRHAGE 2 0.0017
375 ORGAN FAILURE 7 0.0017
376 SLEEP DISORDER 122 0.0017
377 PULMONARY HYPERTENSION 36 0.0017
378 HYPOPITUITARISM 3 0.0017
379 INTENTIONAL PRODUCT MISUSE 151 0.0017
380 BLOOD CREATININE INCREASED 112 0.0017
381 POLYURIA 14 0.0017
382 HYPOVOLAEMIA 10 0.0017
383 PULMONARY OEDEMA 76 0.0017
384 NEONATAL RESPIRATORY DISTRESS SYNDROME 6 0.0017
385 MENTAL STATUS CHANGES 47 0.0017
386 ATRIOVENTRICULAR BLOCK 13 0.0017
387 TRANSPLANT DYSFUNCTION 3 0.0017
388 PULMONARY EMBOLISM 159 0.0017
389 CHRONIC RESPIRATORY FAILURE 2 0.0017
390 DEVICE ALARM ISSUE 3 0.0017
391 RENAL FAILURE 219 0.0016
392 ATRIOVENTRICULAR BLOCK SECOND DEGREE 5 0.0016
393 PNEUMOPERITONEUM 3 0.0016
394 SINUS TACHYCARDIA 23 0.0016
395 ATRIOVENTRICULAR BLOCK FIRST DEGREE 7 0.0016
396 HYPERAMMONAEMIA 8 0.0016
397 CATHETER SITE HAEMORRHAGE 4 0.0016
398 CHOLECYSTITIS ACUTE 9 0.0016
399 ENCEPHALOPATHY 39 0.0016
400 BLOOD BICARBONATE DECREASED 3 0.0016
401 ELECTROCARDIOGRAM QT PROLONGED 57 0.0016
402 KLEBSIELLA INFECTION 8 0.0016
403 BLOOD CREATINE INCREASED 7 0.0016
404 TOXIC ENCEPHALOPATHY 8 0.0016
405 RENAL FAILURE ACUTE 67 0.0016
406 ABORTION MISSED 2 0.0016
407 HYPERKALAEMIA 55 0.0016
408 ADRENOCORTICAL INSUFFICIENCY ACUTE 3 0.0015
409 ACUTE HEPATIC FAILURE 21 0.0015
410 BACTERIAL SEPSIS 5 0.0015
411 PROCEDURAL HAEMORRHAGE 6 0.0015
412 OBSTRUCTIVE AIRWAYS DISORDER 17 0.0015
413 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 4 0.0015
414 BUNDLE BRANCH BLOCK RIGHT 7 0.0015
415 IRON DEFICIENCY ANAEMIA 14 0.0015
416 COMA 72 0.0015
417 EMPYEMA 3 0.0015
418 INJURY 106 0.0015
419 ATRIAL FLUTTER 12 0.0015
420 MYOCARDIAL ISCHAEMIA 17 0.0015
421 DEPRESSED LEVEL OF CONSCIOUSNESS 59 0.0015
422 TACHYCARDIA 130 0.0015
423 CARDIOTOXICITY 13 0.0015
424 DRUG INTOLERANCE 140 0.0014
425 RASH MORBILLIFORM 4 0.0014
426 DISCHARGE 2 0.0014
427 ECHOCARDIOGRAM ABNORMAL 2 0.0014
428 PREMATURE BABY 43 0.0014
429 PULMONARY ALVEOLAR HAEMORRHAGE 8 0.0014
430 STAPHYLOCOCCUS TEST POSITIVE 3 0.0014
431 SWELLING 133 0.0014
432 STAPHYLOCOCCAL SEPSIS 7 0.0014
433 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
434 CATHETER SITE ERYTHEMA 3 0.0014
435 TACHYPNOEA 19 0.0014
436 RENAL IMPAIRMENT 117 0.0014
437 PLEURAL EFFUSION 83 0.0014
438 HYPOGLYCAEMIA 66 0.0014
439 RETROPERITONEAL HAEMATOMA 3 0.0014
440 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 8 0.0013
441 BACTERAEMIA 16 0.0013
442 HISTIOCYTOSIS HAEMATOPHAGIC 4 0.0013
443 CONDITION AGGRAVATED 405 0.0013
444 MITRAL VALVE INCOMPETENCE 15 0.0013
445 TOXIC EPIDERMAL NECROLYSIS 20 0.0013
446 ASPARTATE AMINOTRANSFERASE ABNORMAL 2 0.0013
447 THERAPY NON-RESPONDER 59 0.0013
448 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
449 UNEVALUABLE EVENT 99 0.0013
450 PANCREATITIS NECROTISING 3 0.0013
451 LOWER RESPIRATORY TRACT INFECTION 59 0.0013
452 ABDOMINAL PAIN 301 0.0013
453 MULTIPLE-DRUG RESISTANCE 4 0.0013
454 PULMONARY HAEMORRHAGE 10 0.0013
455 VENOUS THROMBOSIS 5 0.0013
456 RESPIRATORY RATE DECREASED 4 0.0013
457 ELECTROENCEPHALOGRAM ABNORMAL 4 0.0013
458 CARDIAC TAMPONADE 6 0.0013
459 INTRA-ABDOMINAL HAEMORRHAGE 3 0.0013
460 HAEMOPTYSIS 35 0.0013
461 ACUTE PULMONARY OEDEMA 7 0.0012
462 MYDRIASIS 16 0.0012
463 CHROMATURIA 28 0.0012
464 CONSTIPATION 270 0.0012
465 TRANSPLANT FAILURE 3 0.0012
466 HYPERTONIA 7 0.0012
467 ANAPHYLACTOID REACTION 5 0.0012
468 HEPATOTOXICITY 27 0.0012
469 HYPOPHAGIA 31 0.0012
470 GENERALISED TONIC-CLONIC SEIZURE 20 0.0012
471 PULMONARY MASS 18 0.0012
472 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 9 0.0012
473 HYPERTRIGLYCERIDAEMIA 7 0.0012
474 ABDOMINAL INFECTION 3 0.0012
475 PROTHROMBIN TIME PROLONGED 7 0.0012
476 JOINT INJURY 25 0.0012
477 INFARCTION 8 0.0012
478 HEPATOSPLENOMEGALY 3 0.0012
479 FLUID OVERLOAD 17 0.0012
480 HAEMOLYSIS 9 0.0012
481 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 3 0.0012
482 UNRESPONSIVE TO STIMULI 30 0.0012
483 HYPERBILIRUBINAEMIA 12 0.0012
484 HYPOALBUMINAEMIA 9 0.0012
485 SKIN NECROSIS 6 0.0012
486 MUCORMYCOSIS 3 0.0012
487 ADRENAL INSUFFICIENCY 14 0.0012
488 PULMONARY FUNCTION TEST DECREASED 5 0.0011
489 TUMOUR LYSIS SYNDROME 10 0.0011
490 LOW BIRTH WEIGHT BABY 9 0.0011
491 HEPATIC FAILURE 34 0.0011
492 SUICIDE ATTEMPT 67 0.0011
493 DECUBITUS ULCER 9 0.0011
494 NORMAL NEWBORN 6 0.0011
495 COVID-19 PNEUMONIA 13 0.0011
496 CLONUS 3 0.0011
497 SUBDURAL HAEMORRHAGE 3 0.0011
498 IMMUNE THROMBOCYTOPENIA 5 0.0011
499 PNEUMONIA ASPIRATION 27 0.0011
500 OXYGEN SATURATION ABNORMAL 3 0.0011
501 GENERALISED OEDEMA 13 0.0010
502 RENAL FAILURE CHRONIC 8 0.0010
503 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
504 DRUG INEFFECTIVE 1360 0.0010
505 SKIN WARM 6 0.0010
506 GASTROINTESTINAL NECROSIS 3 0.0010
507 NEUROTOXICITY 18 0.0010
508 APLASIA 2 0.0010
509 LUNG INFILTRATION 9 0.0010
510 CYANOSIS 16 0.0010
511 RESPIRATORY DISTRESS 28 0.0010
512 SOMNOLENCE 204 0.0010
513 ABDOMINAL TENDERNESS 5 0.0010
514 DEVICE RELATED SEPSIS 2 0.0010
515 NEPHROGENIC SYSTEMIC FIBROSIS 3 0.0010
516 CORONARY ARTERY DISEASE 30 0.0010
517 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 5 0.0010
518 ENDOCARDITIS 5 0.0010
519 PERIPHERAL VASCULAR DISORDER 5 0.0010
520 ATRIAL THROMBOSIS 2 0.0010
521 ANAEMIA 184 0.0010
522 CONGESTIVE CARDIOMYOPATHY 4 0.0010
523 CARDIO-RESPIRATORY ARREST 40 0.0010
524 BLOOD UREA INCREASED 16 0.0010
525 HAEMODIALYSIS 8 0.0010
526 ATRIAL TACHYCARDIA 2 0.0010
527 ELECTROLYTE IMBALANCE 11 0.0009
528 POST PROCEDURAL HAEMORRHAGE 11 0.0009
529 NYSTAGMUS 5 0.0009
530 PNEUMONIA VIRAL 3 0.0009
531 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
532 PULMONARY FIBROSIS 18 0.0009
533 DIALYSIS 13 0.0009
534 RESPIRATORY RATE INCREASED 8 0.0009
535 EJECTION FRACTION DECREASED 14 0.0009
536 PULMONARY ARTERIAL HYPERTENSION 13 0.0009
537 CORNEAL OEDEMA 2 0.0009
538 ANGIOPATHY 5 0.0009
539 BLOOD ALBUMIN DECREASED 7 0.0009
540 VASCULAR DEVICE INFECTION 4 0.0009
541 ECCHYMOSIS 6 0.0009
542 LEFT VENTRICULAR FAILURE 3 0.0009
543 PERITONITIS 18 0.0009
544 CARDIOVASCULAR DISORDER 22 0.0009
545 NEPHROGENIC ANAEMIA 4 0.0009
546 SHOCK HAEMORRHAGIC 7 0.0009
547 ESCHERICHIA BACTERAEMIA 2 0.0008
548 LUNG TRANSPLANT 3 0.0008
549 HYPOKALAEMIA 39 0.0008
550 FIBRIN D DIMER INCREASED 3 0.0008
551 PRODUCT CONTAMINATION 3 0.0008
552 SUBDURAL HAEMATOMA 12 0.0008
553 FACIAL BONES FRACTURE 3 0.0008
554 UPPER GASTROINTESTINAL HAEMORRHAGE 14 0.0008
555 OVERDOSE 179 0.0008
556 HYPERGLYCAEMIA 30 0.0008
557 BLOOD PRESSURE DECREASED 54 0.0008
558 LOWER GASTROINTESTINAL HAEMORRHAGE 6 0.0008
559 MYOPATHY 7 0.0008
560 MALNUTRITION 9 0.0008
561 INTESTINAL PERFORATION 9 0.0008
562 EXCORIATION 2 0.0008
563 CEREBRAL ISCHAEMIA 4 0.0008
564 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
565 PNEUMONIA BACTERIAL 7 0.0008
566 EXFOLIATIVE RASH 2 0.0008
567 PULMONARY CONGESTION 10 0.0008
568 SERUM FERRITIN INCREASED 4 0.0008
569 PNEUMOTHORAX 12 0.0008
570 PRODUCT USE IN UNAPPROVED INDICATION 187 0.0008
571 AZOTAEMIA 3 0.0008
572 CARDIAC FAILURE ACUTE 5 0.0007
573 AREFLEXIA 2 0.0007
574 DELIRIUM 26 0.0007
575 BLOOD DISORDER 6 0.0007
576 MUSCLE HAEMORRHAGE 3 0.0007
577 BLOOD BILIRUBIN INCREASED 20 0.0007
578 ABDOMINAL RIGIDITY 2 0.0007
579 INTERNATIONAL NORMALISED RATIO INCREASED 21 0.0007
580 HAEMORRHAGE INTRACRANIAL 11 0.0007
581 THROMBOCYTOPENIA 82 0.0007
582 ATRIAL FIBRILLATION 71 0.0007
583 LEG AMPUTATION 3 0.0007
584 DRUG LEVEL INCREASED 12 0.0007
585 SINUS BRADYCARDIA 7 0.0007
586 ENCEPHALITIS 5 0.0007
587 CHOLECYSTITIS INFECTIVE 2 0.0007
588 DEVICE RELATED INFECTION 11 0.0007
589 UPPER RESPIRATORY TRACT INFECTION 33 0.0007
590 CARDIAC FAILURE CHRONIC 3 0.0007
591 BRONCHOSPASM 10 0.0007
592 ALANINE AMINOTRANSFERASE INCREASED 43 0.0007
593 PSEUDOMONAS INFECTION 6 0.0007
594 DUODENAL ULCER HAEMORRHAGE 2 0.0007
595 CEREBRAL INFARCTION 17 0.0007
596 ESCHERICHIA SEPSIS 2 0.0007
597 ADENOVIRUS INFECTION 2 0.0007
598 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
599 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 7 0.0007
600 TRANSIENT ISCHAEMIC ATTACK 23 0.0007
601 VOMITING 320 0.0007
602 ACUTE MYOCARDIAL INFARCTION 20 0.0007
603 CYTOMEGALOVIRUS VIRAEMIA 3 0.0007
604 RASH MACULO-PAPULAR 15 0.0007
605 MATERNAL EXPOSURE DURING PREGNANCY 60 0.0007
606 ILEUS PARALYTIC 3 0.0007
607 CHOLECYSTITIS 8 0.0007
608 SUSPECTED OFF LABEL USE 3 0.0007
609 MUSCULOSKELETAL STIFFNESS 58 0.0007
610 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
611 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
612 PROCEDURAL COMPLICATION 5 0.0007
613 CARDIOMEGALY 8 0.0006
614 SMALL INTESTINAL OBSTRUCTION 8 0.0006
615 DIFFUSE LARGE B-CELL LYMPHOMA 5 0.0006
616 FEBRILE NEUTROPENIA 43 0.0006
617 HYPERCALCAEMIA 8 0.0006
618 ALTERED STATE OF CONSCIOUSNESS 14 0.0006
619 EMOTIONAL DISTRESS 78 0.0006
620 OFF LABEL USE 560 0.0006
621 ABORTION INDUCED 6 0.0006
622 DRUG INTERACTION 101 0.0006
623 CARDIAC FAILURE 51 0.0006
624 COLITIS 24 0.0006
625 PARALYSIS 9 0.0006
626 POST PROCEDURAL COMPLICATION 12 0.0006
627 TRANSPLANT REJECTION 5 0.0006
628 OEDEMA PERIPHERAL 75 0.0006
629 ARRHYTHMIA 29 0.0006
630 MYOCARDITIS 7 0.0006
631 ESCHERICHIA INFECTION 5 0.0006
632 OXYGEN SATURATION DECREASED 34 0.0006
633 CANDIDA INFECTION 10 0.0006
634 WRONG PRODUCT ADMINISTERED 4 0.0006
635 SUBARACHNOID HAEMORRHAGE 6 0.0006
636 PETIT MAL EPILEPSY 3 0.0006
637 PERIPHERAL COLDNESS 8 0.0006
638 CERVICAL VERTEBRAL FRACTURE 2 0.0006
639 PERIORBITAL OEDEMA 3 0.0006
640 VENTRICULAR EXTRASYSTOLES 6 0.0006
641 LARGE INTESTINE PERFORATION 4 0.0006
642 HYPERTRANSAMINASAEMIA 4 0.0006
643 ACCIDENTAL OVERDOSE 21 0.0006
644 EMBOLIC STROKE 2 0.0006
645 CONJUNCTIVAL HYPERAEMIA 2 0.0006
646 PRODUCT PRESCRIBING ISSUE 12 0.0006
647 UROSEPSIS 5 0.0005
648 FOETAL EXPOSURE DURING PREGNANCY 44 0.0005
649 HYPOCALCAEMIA 10 0.0005
650 PRODUCT PACKAGING ISSUE 5 0.0005
651 DEVICE FAILURE 8 0.0005
652 VENTRICULAR SEPTAL DEFECT 3 0.0005
653 COMMUNICATION DISORDER 2 0.0005
654 ENTEROCOLITIS 3 0.0005
655 PANCYTOPENIA 29 0.0005
656 LIVER DISORDER 23 0.0005
657 ATELECTASIS 5 0.0005
658 HAEMORRHAGE 54 0.0005
659 LUNG DISORDER 25 0.0005
660 DRUG RESISTANCE 13 0.0005
661 HAEMATOCRIT DECREASED 10 0.0005
662 POLYNEUROPATHY 6 0.0005
663 CREATININE RENAL CLEARANCE DECREASED 2 0.0005
664 EXPOSURE DURING PREGNANCY 31 0.0005
665 CANDIDIASIS 2 0.0005
666 PNEUMONIA 161 0.0005
667 HYPERTENSION 105 0.0005
668 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
669 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 3 0.0005
670 STAPHYLOCOCCAL INFECTION 16 0.0005
671 MULTIPLE INJURIES 3 0.0005
672 ANAPHYLACTIC REACTION 26 0.0005
673 AORTIC VALVE INCOMPETENCE 2 0.0005
674 HEPATITIS ACUTE 3 0.0005
675 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
676 CATHETERISATION CARDIAC 2 0.0005
677 PRODUCT LABEL ISSUE 3 0.0004
678 DRUG TOXICITY 6 0.0004
679 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
680 BLOOD POTASSIUM INCREASED 7 0.0004
681 EXTRASYSTOLES 3 0.0004
682 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
683 SKIN DISCOLOURATION 19 0.0004
684 HYPOKINESIA 6 0.0004
685 COMPLICATION ASSOCIATED WITH DEVICE 6 0.0004
686 MELAENA 9 0.0004
687 GASTROINTESTINAL HAEMORRHAGE 34 0.0004
688 PSYCHIATRIC SYMPTOM 3 0.0004
689 CEREBRAL DISORDER 3 0.0004
690 STEVENS-JOHNSON SYNDROME 9 0.0004
691 BLOOD ALKALINE PHOSPHATASE INCREASED 10 0.0004
692 HYPOTONIA 4 0.0004
693 DRUG TOLERANCE 2 0.0004
694 DRUG LEVEL DECREASED 4 0.0004
695 HYPERTHERMIA 3 0.0004
696 AMMONIA INCREASED 2 0.0004
697 INTERCEPTED PRODUCT ADMINISTRATION ERROR 3 0.0004
698 APNOEA 3 0.0004
699 HAEMORRHAGIC STROKE 3 0.0004
700 HEART RATE INCREASED 38 0.0004
701 APLASTIC ANAEMIA 2 0.0004
702 SEIZURE 44 0.0004
703 SUDDEN DEATH 4 0.0004
704 TRICUSPID VALVE INCOMPETENCE 3 0.0004
705 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 11 0.0004
706 ANAL ABSCESS 2 0.0004
707 GASTRIC ULCER 7 0.0004
708 NAUSEA 291 0.0004
709 ANXIETY 104 0.0004
710 DRUG LEVEL BELOW THERAPEUTIC 2 0.0004
711 HAEMOGLOBIN DECREASED 37 0.0004
712 LIVE BIRTH 3 0.0004
713 BLOOD CALCIUM DECREASED 4 0.0004
714 DEEP VEIN THROMBOSIS 23 0.0004
715 NERVOUS SYSTEM DISORDER 11 0.0004
716 CARDIAC FAILURE CONGESTIVE 28 0.0003
717 HEPATIC FUNCTION ABNORMAL 13 0.0003
718 CARDIAC MURMUR 3 0.0003
719 PERICARDIAL EFFUSION 8 0.0003
720 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
721 PURPURA 3 0.0003
722 WHEEZING 20 0.0003
723 WRONG DRUG ADMINISTERED 3 0.0003
724 MYOCLONUS 4 0.0003
725 MUSCLE RIGIDITY 4 0.0003
726 JAUNDICE 9 0.0003
727 RESPIRATORY DISORDER 10 0.0003
728 DIABETIC KETOACIDOSIS 8 0.0003
729 PATHOGEN RESISTANCE 3 0.0003
730 PLATELET COUNT DECREASED 35 0.0003
731 NO THERAPEUTIC RESPONSE 4 0.0003
732 GRAND MAL CONVULSION 3 0.0003
733 FAECES DISCOLOURED 7 0.0003
734 DYSPNOEA 182 0.0003
735 NEPHROPATHY 3 0.0003
736 THERAPY PARTIAL RESPONDER 5 0.0003
737 EPSTEIN-BARR VIRUS INFECTION 2 0.0003
738 BLOOD SODIUM DECREASED 6 0.0003
739 NEUTROPENIA 43 0.0003
740 RECALLED PRODUCT ADMINISTERED 3 0.0003
741 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 3 0.0003
742 LETHARGY 18 0.0003
743 LIVER FUNCTION TEST ABNORMAL 9 0.0003
744 THROMBOTIC MICROANGIOPATHY 3 0.0003
745 VITAMIN D DEFICIENCY 3 0.0003
746 CEREBRAL HAEMORRHAGE 11 0.0003
747 ASPERGILLUS INFECTION 2 0.0003
748 DISABILITY 6 0.0003
749 BLOOD PRESSURE ABNORMAL 6 0.0003
750 PERITONITIS BACTERIAL 3 0.0003
751 BODY TEMPERATURE INCREASED 6 0.0003
752 PNEUMONITIS 8 0.0003
753 PETECHIAE 3 0.0003
754 TRANSFUSION 3 0.0003
755 EOSINOPHILIA 5 0.0003
756 LIVER INJURY 7 0.0003
757 DUODENAL ULCER 2 0.0003
758 DIVERTICULUM 2 0.0003
759 RECTAL HAEMORRHAGE 12 0.0003
760 TREATMENT FAILURE 23 0.0003
761 HYPERTHYROIDISM 4 0.0003
762 HAEMATEMESIS 7 0.0003
763 OSTEOMYELITIS 5 0.0003
764 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
765 WOUND INFECTION 3 0.0003
766 DEATH 236 0.0003
767 AGITATION 20 0.0003
768 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
769 BLINDNESS TRANSIENT 2 0.0003
770 DISEASE PROGRESSION 32 0.0003
771 GASTROINTESTINAL DISORDER 24 0.0003
772 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
773 REBOUND EFFECT 3 0.0003
774 ASTHMA 30 0.0003
775 GASTRIC HAEMORRHAGE 3 0.0003
776 EMOTIONAL DISORDER 8 0.0003
777 ACUTE MYELOID LEUKAEMIA 4 0.0003
778 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
779 RESPIRATORY ARREST 7 0.0003
780 NEUROLEPTIC MALIGNANT SYNDROME 3 0.0003
781 GASTROOESOPHAGEAL REFLUX DISEASE 20 0.0002
782 MUSCLE TIGHTNESS 4 0.0002
783 PANCREATITIS 13 0.0002
784 PYREXIA 85 0.0002
785 PAIN 150 0.0002
786 CYTOMEGALOVIRUS INFECTION 4 0.0002
787 WHITE BLOOD CELL COUNT INCREASED 9 0.0002
788 HAEMATOMA 6 0.0002
789 DISEASE RECURRENCE 11 0.0002
790 NERVOUSNESS 12 0.0002
791 SEDATION 6 0.0002
792 SARS-COV-2 TEST POSITIVE 3 0.0002
793 DIABETES MELLITUS INADEQUATE CONTROL 4 0.0002
794 ISCHAEMIC STROKE 4 0.0002
795 CELLULITIS 11 0.0002
796 HEPATIC STEATOSIS 4 0.0002
797 THINKING ABNORMAL 4 0.0002
798 WITHDRAWAL SYNDROME 9 0.0002
799 ARTERIOSCLEROSIS 2 0.0002
800 PAIN IN JAW 6 0.0002
801 FUNGAL INFECTION 7 0.0002
802 URINARY RETENTION 7 0.0002
803 MENTAL DISORDER 9 0.0002
804 PRESYNCOPE 5 0.0002
805 OEDEMA 11 0.0002
806 DRUG WITHDRAWAL SYNDROME NEONATAL 3 0.0002
807 HEART RATE DECREASED 7 0.0002
808 TREMOR 33 0.0002
809 EMPHYSEMA 2 0.0002
810 ECONOMIC PROBLEM 3 0.0002
811 MEDICATION ERROR 11 0.0002
812 CHRONIC KIDNEY DISEASE 15 0.0002
813 BONE MARROW FAILURE 4 0.0002
814 BLINDNESS 8 0.0002
815 DRUG DISPENSING ERROR 3 0.0002
816 PRODUCT PREPARATION ERROR 4 0.0002
817 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
818 LUNG INFECTION 3 0.0002
819 C-REACTIVE PROTEIN INCREASED 7 0.0002
820 COMPLETED SUICIDE 16 0.0002
821 HEPATIC ENZYME INCREASED 13 0.0002
822 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
823 OBESITY 3 0.0002
824 PRODUCT DISPENSING ERROR 4 0.0002
825 METASTASES TO BONE 3 0.0002
826 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
827 SKIN DISORDER 6 0.0002
828 PANCREATITIS ACUTE 4 0.0002
829 FACE OEDEMA 3 0.0002
830 FLUID RETENTION 9 0.0002
831 HAEMATURIA 6 0.0002
832 RED BLOOD CELL COUNT DECREASED 5 0.0002
833 MUSCLE TWITCHING 4 0.0002
834 CAESAREAN SECTION 2 0.0002
835 RASH MACULAR 6 0.0002
836 DEPRESSION 39 0.0002
837 SYNCOPE 17 0.0002
838 PSYCHOTIC DISORDER 5 0.0002
839 DRUG ABUSE 14 0.0002
840 INTERSTITIAL LUNG DISEASE 8 0.0002
841 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
842 BONE DISORDER 3 0.0002
843 TREATMENT NONCOMPLIANCE 9 0.0002
844 HEPATIC CIRRHOSIS 3 0.0002
845 COVID-19 28 0.0002
846 DYSPNOEA EXERTIONAL 6 0.0002
847 ABDOMINAL PAIN LOWER 4 0.0002
848 CHOLESTASIS 3 0.0002
849 LOSS OF CONSCIOUSNESS 20 0.0002
850 EXPIRED PRODUCT ADMINISTERED 5 0.0002
851 MYOCARDIAL INFARCTION 26 0.0001
852 PRODUCT USE ISSUE 28 0.0001
853 PRODUCT ADMINISTRATION ERROR 3 0.0001
854 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
855 CEREBROVASCULAR ACCIDENT 25 0.0001
856 HYPERHIDROSIS 19 0.0001
857 PALLOR 4 0.0001
858 RIB FRACTURE 3 0.0001
859 ASTHENIA 54 0.0001
860 BLISTER 8 0.0001
861 CONFUSIONAL STATE 23 0.0001
862 DEVICE OCCLUSION 2 0.0001
863 URINARY TRACT INFECTION 24 0.0001
864 CONVULSION 8 0.0001
865 THERAPY CESSATION 7 0.0001
866 DYSARTHRIA 5 0.0001
867 HEART RATE IRREGULAR 3 0.0001
868 NO ADVERSE EVENT 24 0.0001
869 COUGH 36 0.0001
870 HAEMATOCHEZIA 7 0.0001
871 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
872 CHOLELITHIASIS 4 0.0001
873 OSTEONECROSIS 4 0.0001
874 ABDOMINAL PAIN UPPER 25 0.0001
875 LEUKOPENIA 6 0.0001
876 DEHYDRATION 16 0.0001
877 CHILLS 14 0.0001
878 ANAPHYLACTIC SHOCK 3 0.0001
879 NIGHTMARE 4 0.0001
880 GASTRITIS 3 0.0001
881 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
882 MYELOSUPPRESSION 4 0.0001
883 THROAT TIGHTNESS 3 0.0001
884 SKIN LESION 3 0.0001
885 INFUSION RELATED REACTION 7 0.0001
886 BLOOD URINE PRESENT 2 0.0001
887 PLASMA CELL MYELOMA 4 0.0001
888 PRODUCT DOSE OMISSION ISSUE 30 0.0001
889 URINARY INCONTINENCE 3 0.0001
890 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
891 BLOOD POTASSIUM DECREASED 3 0.0001
892 THERAPEUTIC RESPONSE DECREASED 6 0.0001
893 DRUG ADMINISTRATION ERROR 3 0.0001
894 INFECTION 14 0.0001
895 POLLAKIURIA 4 0.0001
896 DRUG-INDUCED LIVER INJURY 3 0.0001
897 HEAD INJURY 3 0.0001
898 MOOD SWINGS 3 0.0001
899 MOVEMENT DISORDER 3 0.0001
900 NIGHT SWEATS 3 0.0001
901 HALLUCINATION 7 0.0001
902 DEVICE LEAKAGE 4 0.0001
903 CHEST PAIN 17 0.0001
904 IMPAIRED HEALING 3 0.0001
905 ANGIOEDEMA 4 0.0001
906 THERAPEUTIC RESPONSE UNEXPECTED 4 0.0001
907 VISUAL IMPAIRMENT 11 0.0001
908 COGNITIVE DISORDER 4 0.0001
909 PRODUCTIVE COUGH 4 0.0001
910 BLOOD PRESSURE FLUCTUATION 2 0.0001
911 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
912 PRODUCT QUALITY ISSUE 11 0.0001
913 EPISTAXIS 6 0.0001
914 INTESTINAL OBSTRUCTION 3 0.0001
915 CHEST DISCOMFORT 8 0.0001
916 DEVICE ISSUE 7 0.0001
917 DISORIENTATION 3 0.0001
918 HYPERSENSITIVITY 14 0.0001
919 HEADACHE 47 0.0001
920 DEVICE BREAKAGE 3 0.0001
921 DYSPHAGIA 7 0.0001
922 NEUTROPHIL COUNT DECREASED 3 0.0001
923 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
924 NECK PAIN 4 0.0001
925 VAGINAL HAEMORRHAGE 3 0.0001
926 DYSPHONIA 4 0.0001
927 DIARRHOEA 44 0.0001
928 BRONCHITIS 5 0.0001
929 APHASIA 2 0.0001
930 FATIGUE 51 0.0001
931 FEELING HOT 4 0.0001
932 DECREASED APPETITE 15 0.0001
933 BLOOD GLUCOSE DECREASED 3 0.0001
934 AMNESIA 4 0.0001
935 PALPITATIONS 7 0.0001
936 MALIGNANT NEOPLASM PROGRESSION 6 0.0001
937 MOBILITY DECREASED 4 0.0001
938 RASH 24 0.0001
939 CRYING 2 0.0001
940 OROPHARYNGEAL PAIN 5 0.0001
941 MUSCULAR WEAKNESS 6 0.0001
942 PRODUCT SUBSTITUTION ISSUE 3 0.0001
943 CONTUSION 5 0.0001
944 IRRITABILITY 3 0.0000
945 STOMATITIS 3 0.0000
946 EXTRA DOSE ADMINISTERED 2 0.0000
947 DYSKINESIA 2 0.0000
948 SINUSITIS 5 0.0000
949 ERYTHEMA 10 0.0000
950 INFLUENZA LIKE ILLNESS 4 0.0000
951 FALL 16 0.0000
952 SKIN EXFOLIATION 4 0.0000
953 RHINORRHOEA 3 0.0000
954 BLOOD PRESSURE INCREASED 7 0.0000
955 DRUG WITHDRAWAL SYNDROME 4 0.0000
956 PERIPHERAL SWELLING 7 0.0000
957 INCORRECT DOSE ADMINISTERED 10 0.0000
958 SUICIDAL IDEATION 4 0.0000
959 MUSCLE SPASMS 8 0.0000
960 CARDIAC DISORDER 4 0.0000
961 DEVICE MALFUNCTION 3 0.0000
962 BLOOD GLUCOSE INCREASED 8 0.0000
963 NEUROPATHY PERIPHERAL 4 0.0000
964 INSOMNIA 11 0.0000
965 PAIN IN EXTREMITY 12 0.0000
966 HYPOAESTHESIA 6 0.0000
967 DRY EYE 2 0.0000
968 WEIGHT DECREASED 11 0.0000
969 MALAISE 17 0.0000
970 PARAESTHESIA 6 0.0000
971 DEPRESSED MOOD 2 0.0000
972 DRUG EFFECT DECREASED 2 0.0000
973 DISTURBANCE IN ATTENTION 2 0.0000
974 ABDOMINAL DISCOMFORT 6 0.0000
975 WEIGHT INCREASED 8 0.0000
976 MYALGIA 6 0.0000
977 BALANCE DISORDER 3 0.0000
978 BONE PAIN 2 0.0000
979 HOSPITALISATION 5 0.0000
980 DIZZINESS 16 0.0000
981 GAIT DISTURBANCE 6 0.0000
982 ARTHRALGIA 13 0.0000
983 BACK PAIN 7 0.0000
984 URTICARIA 5 0.0000
985 FLUSHING 3 0.0000
986 MEMORY IMPAIRMENT 4 0.0000
987 NASOPHARYNGITIS 5 0.0000
988 ADVERSE EVENT 2 0.0000
989 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
990 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
991 PRURITUS 5 0.0000
992 FEELING ABNORMAL 3 0.0000
993 DRUG DOSE OMISSION 2 0.0000
994 ALOPECIA 2 0.0000